Clinical Trial Update: Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oral ubrogepant for acute treatment of migraine during the prodrome phase in adults has completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Ubrogepant (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-05-31